66 related articles for article (PubMed ID: 32711431)
1. Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.
Yuan JM; Fan Y; Ognjanovic S; Wang R; Van Den Berg D; Govindarajan S; Yu MC
BMC Gastroenterol; 2013 Feb; 13():32. PubMed ID: 23419149
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.
Gehrau RC; Archer KJ; Mas VR; Maluf DG
PLoS One; 2012; 7(7):e40275. PubMed ID: 22792259
[TBL] [Abstract][Full Text] [Related]
4. Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma.
Zecca A; Barili V; Canetti D; Regina V; Olivani A; Carone C; Capizzuto V; Zerbato B; Trenti T; Dalla Valle R; Ferrari C; Cariani E; Missale G
Cancer Immunol Immunother; 2020 Aug; 69(8):1589-1603. PubMed ID: 32307580
[TBL] [Abstract][Full Text] [Related]
5. Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.
Plissonnier ML; Lahlali T; Michelet M; Lebossé F; Cottarel J; Beer M; Neveu G; Durantel D; Bartosch B; Accardi R; Clément S; Paradisi A; Devouassoux-Shisheboran M; Einav S; Mehlen P; Zoulim F; Parent R
PLoS Biol; 2016 Mar; 14(3):e1002421. PubMed ID: 27031829
[TBL] [Abstract][Full Text] [Related]
6. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.
Lo PH; Urabe Y; Kumar V; Tanikawa C; Koike K; Kato N; Miki D; Chayama K; Kubo M; Nakamura Y; Matsuda K
PLoS One; 2013; 8(4):e61279. PubMed ID: 23593449
[TBL] [Abstract][Full Text] [Related]
7. Association of C-myc and p53 Gene Expression and Polymorphisms with Hepatitis C (HCV) Chronic Infection, Cirrhosis and Hepatocellular Carcinoma (HCC) Stages in Egypt.
Koutb F; Abdel-Rahman S; Hassona E; Haggag A
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2049-2057. PubMed ID: 28843220
[TBL] [Abstract][Full Text] [Related]
8.
Wang Y; Gao F; Lu J
Nucleosides Nucleotides Nucleic Acids; 2024 May; ():1-11. PubMed ID: 38728583
[TBL] [Abstract][Full Text] [Related]
9. Role of estrogens and epidermal growth factor in hepatocellular carcinoma (HCC).
Francavilla A; Panella C; Amoruso A; Giangaspero A; Gennari L; Mazzaferro V; Colella G; Van Thiel DH; Starzl TE
Dig Dis Sci; 1991 Sep; 36(9):1299-302. PubMed ID: 1654242
[TBL] [Abstract][Full Text] [Related]
10. Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy.
Motomura T; Ono Y; Shirabe K; Fukuhara T; Konishi H; Mano Y; Toshima T; Yoshiya S; Muto J; Ikegami T; Yoshizumi T; Maehara Y
HPB Surg; 2012; 2012():185496. PubMed ID: 23132957
[TBL] [Abstract][Full Text] [Related]
11. Liver Transplantation for Hepatocellular Carcinoma among African Americans in the United States.
Sourianarayanane A; Aucejo F; Miller C; Lopez R; Zein NN; McCullough AJ; Menon KV
Int J Organ Transplant Med; 2012; 3(2):85-91. PubMed ID: 25013628
[TBL] [Abstract][Full Text] [Related]
12. Contribution of PNPLA3 gene polymorphisms to hepatocellular carcinoma susceptibility in the Chinese Han population.
Gong D; Li S; Yu Z; Wang K; Qiao X; Wu C
BMC Med Genomics; 2022 Nov; 15(1):248. PubMed ID: 36447249
[TBL] [Abstract][Full Text] [Related]
13.
Bainrauch A; Šisl D; Markotić A; Ostojić A; Gašparov S; Bralić Lang V; Kovačić N; Grčević D; Mrzljak A; Kelava T
J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640639
[TBL] [Abstract][Full Text] [Related]
14. Insights into Growth Factors in Liver Carcinogenesis and Regeneration: An Ongoing Debate on Minimizing Cancer Recurrence after Liver Resection.
Álvarez-Mercado AI; Caballeria-Casals A; Rojano-Alfonso C; Chávez-Reyes J; Micó-Carnero M; Sanchez-Gonzalez A; Casillas-Ramírez A; Gracia-Sancho J; Peralta C
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572344
[TBL] [Abstract][Full Text] [Related]
15. EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.
Wang J; Zhong Y; Meng G
Int J Clin Oncol; 2021 Nov; 26(11):2053-2064. PubMed ID: 34291370
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
[TBL] [Abstract][Full Text] [Related]
17. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
Li Y; Xie Q; Lu F; Zhao J; Mao P; Li Z; Liu S; Zhuang H
Liver Int; 2010 Jan; 30(1):112-8. PubMed ID: 19840254
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
[TBL] [Abstract][Full Text] [Related]
19. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
